TipRanks
Go Ultimate55% OFF

Ardelyx (ARDX) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Tenapanor 25 Mg Bid, Tenapanor 5 Mg Bid, Tenapanor 50 Mg BidChronic Idiopathic Constipation (Cic)Phase IIIRecruitingA 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in AdultsJan 26, 2026―
TenapanorIrritable Bowel Syndrome With Constipation (Ibs-C)Phase IIActive Not Recruiting4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 YrsAug 12, 2024
TenapanorIrritable Bowel Syndrome With Constipation (Ibs-C)Phase IIIEnrolling By InvitationSafety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-CMar 07, 2023
Tenapanor 50 Mg, Tenapanor 25 Mg BidIrritable Bowel Syndrome With Constipation (Ibs-C)Phase IIIActive Not RecruitingStudy to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 YearsNov 30, 2022

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Ardelyx Inc (ARDX) have in its pipeline
Ardelyx ARDX is currently developing the following drugs: Tenapanor 25 Mg Bid, Tenapanor 5 Mg Bid, Tenapanor 50 Mg Bid, Tenapanor, Tenapanor 50 Mg, Tenapanor 25 Mg Bid. These drug candidates are in various stages of clinical development as the company works toward FDA approval.